Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| glutamatergic neuron | 4 studies | 39% ± 11% | |
| GABAergic neuron | 4 studies | 36% ± 9% | |
| retinal bipolar neuron | 3 studies | 17% ± 1% | |
| rod bipolar cell | 3 studies | 27% ± 3% | |
| interneuron | 3 studies | 35% ± 14% |
Insufficient scRNA-seq data for expression of WSCD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 86% | 5015.79 | 2264 / 2642 | 62% | 4.71 | 434 / 705 |
| thymus | 100% | 3765.63 | 650 / 653 | 44% | 8.01 | 269 / 605 |
| prostate | 64% | 711.07 | 156 / 245 | 73% | 2.76 | 365 / 502 |
| uterus | 92% | 1722.85 | 157 / 170 | 20% | 2.03 | 94 / 459 |
| esophagus | 65% | 2270.94 | 940 / 1445 | 26% | 2.01 | 48 / 183 |
| bladder | 48% | 461.86 | 10 / 21 | 38% | 3.17 | 190 / 504 |
| blood vessel | 57% | 539.68 | 755 / 1335 | 0% | 0 | 0 / 0 |
| intestine | 42% | 379.88 | 405 / 966 | 10% | 0.37 | 54 / 527 |
| stomach | 27% | 307.28 | 98 / 359 | 19% | 1.04 | 53 / 286 |
| pancreas | 1% | 2.86 | 2 / 328 | 44% | 1.82 | 78 / 178 |
| tonsil | 0% | 0 | 0 / 0 | 33% | 2.42 | 15 / 45 |
| adrenal gland | 4% | 34.50 | 11 / 258 | 25% | 1.65 | 58 / 230 |
| breast | 17% | 104.26 | 77 / 459 | 12% | 0.54 | 134 / 1118 |
| kidney | 18% | 85.55 | 16 / 89 | 9% | 0.48 | 79 / 901 |
| lung | 2% | 6.24 | 9 / 578 | 23% | 1.33 | 262 / 1155 |
| ovary | 4% | 20.37 | 8 / 180 | 19% | 1.02 | 82 / 430 |
| adipose | 12% | 89.30 | 147 / 1204 | 0% | 0 | 0 / 0 |
| skin | 5% | 24.94 | 94 / 1809 | 4% | 0.16 | 20 / 472 |
| eye | 0% | 0 | 0 / 0 | 9% | 0.31 | 7 / 80 |
| heart | 2% | 9.72 | 18 / 861 | 0% | 0 | 0 / 0 |
| liver | 0% | 0 | 0 / 226 | 1% | 0.03 | 3 / 406 |
| muscle | 0% | 1.60 | 2 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0008146 | Molecular function | sulfotransferase activity |
| Gene name | WSCD2 |
| Protein name | Sialate:O-sulfotransferase 2 (WSC domain-containing protein 2) WSC domain containing 2 |
| Synonyms | KIAA0789 |
| Description | FUNCTION: Sialate:O-sulfotransferase which catalyzes 8-O-sulfation at the Sia-glycan level using 3'-phosphoadenosine 5'-phosphosulfate (PAPS) as a donor, forming 8-O-sulfated Sia (Sia8S)-glycans. Displays selectivity toward glycoproteins such as TF/transferrin. . |
| Accessions | F8W030 Q2TBF2 ENST00000549903.1 [Q2TBF2-2] ENST00000332082.8 [Q2TBF2-1] ENST00000551638.5 ENST00000547525.6 [Q2TBF2-1] |